Bette Jacobs - Dec 13, 2023 Form 4 Insider Report for Shuttle Pharmaceuticals Holdings, Inc. (SHPH)

Role
Director
Signature
/s/ Bette Jacobs
Stock symbol
SHPH
Transactions as of
Dec 13, 2023
Transactions value $
-$1,926
Form type
4
Date filed
12/20/2023, 09:51 PM
Previous filing
Jan 3, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHPH Common Stock Sale -$1.93K -4.16K -13.31% $0.46 27.1K Dec 13, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") held by the Reporting Person. Upon vesting of the RSUs, the sales are automatic, routine, non-discretionary transactions mandated by the Issuer under its equity incentive plan in order to satisfy the Reporting Person's tax withholding obligations which are funded by "sell to cover" transactions. These transactions are exempt under Section 16b-3 and do not represent discretionary trades by the Reporting Person.
F2 Consists of (i) 15,201 shares of common stock and (ii) 11,863 RSUs which remain subject to certain vesting conditions.